088 A phase I/II study on the anti-CD3/CD7 immunotoxin combination for the treatment of steroid-refractory acute GVHD

Authors :: Tiago R. Matos
Frank Preijers
Eric H.G. van Hooren
Ypke V.J.M. van Oosterhout
Christian Reicherts
Nicole M. A. Blijlevens
Walter J.F.M. van der Velden
John E. Levine
Christoph Groth
S. Blok
Matthias Stelljes
L.F. van Groningen
Source :: Journal of Investigative Dermatology. 139:S229
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Phase i ii
business.industry
Immunotoxin
Medicine
Cell Biology
Dermatology
Anti cd3
Pharmacology
business
Steroid refractory
Molecular Biology
Biochemistry

Tools